Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.


TSXV:IBO - Post by User

Post by yukon_goldon Nov 08, 2022 8:14pm
240 Views
Post# 35083931

UNIVERSAL IBOGAINE ANNOUNCES FORMATION OF ADVISORY BOARD

UNIVERSAL IBOGAINE ANNOUNCES FORMATION OF ADVISORY BOARDimage
 

UNIVERSAL IBOGAINE ANNOUNCES FORMATION OF ADVISORY BOARD

Dear Friends, Shareholders and Investors,

To our valued friends family stakeholders and shareholders we are pleased to announce today the formation of a corporate advisory board. We are deeply grateful to the individuals named here who will help to guide and support us on our mission to bring ibogaine to the world.

Read the full news release here.

The individuals named here bring expertise in US federal legislation and advocacy for drug policy reform, clinic franchising and licensing, pharmaceutical drug delivery and wholesale with a particular focus in indigenous communities and clinic and medical facility construction.

Learn more here.

We are continuing to develop our team at the board, advisory and management levels to add strength and depth to our core expertise and develop a world class organization that will deliver on the goals we have set in motion.

We thank you all for your ongoing support for the mission.

Please stay tuned, more news to come.

Nick Karos CEO

 

For any questions, please contact us through info@universalibogaine.com

 

Please let us know if you have have any questions or feedback, we love hearing from our community, we could not do this without you!

Profile Image Universal Ibogaine Info@UniversalIbogaine.com 1 (855) IBOGAINE - (426-4246) UniversalIbogaine.com
 
 
Facebook Twitter LinkedIn YouTube

Universal Ibogaine Inc. 595 Howe Street Suite 303 Vancouver, British Columbia V6C2T5 Canada 1 (855) 426-4246


<< Previous
Bullboard Posts
Next >>